The Danish BioInnovation Institute announced a €9.52 million convertible‑loan programme for 17 early‑stage biotech, healthtech, cleantech and AI startups, aiming to turn university research into commercial companies across Europe.
The BioInnovation Institute (BII) announced an additional €7.8 million grant, split as €1.3 million per company, for six Danish spin‑outs working on antibody cancer therapies, AI‑powered ultrasound, inflammatory disease treatments, biological pest control, vaccine‑based immunotherapies, and waste‑to‑fuel technology. The funding builds on a prior €500 k grant each, bringing total support to €1.8 million per company and includes continued access to BII’s Copenhagen innovation platform.
The Danish BioInnovation Institute launched a new AI Lab designed to shorten the path from academic research to market implementation. The article discusses whether Poland will develop a similar operational mechanism connecting science, startups, administration, industry, VC funds, and data access.